Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
ghrelin opposite strand/antisense RNA | 1.000 | 0.077 |
|
disease | 0.100 | None | 0 | 6 | ||||||||||||
|
potassium inwardly rectifying channel subfamily J member 18 | 0.722 | 0.346 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | 0.534 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SCN1A and SCN9A antisense RNA 1 | 0.636 | 0.346 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
TOP1 binding arginine/serine rich protein | 0.659 | 0.538 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
APC regulator of WNT signaling pathway 2 | 0.582 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
semaphorin 3A | 0.500 | 0.808 | 0.98 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
MER proto-oncogene, tyrosine kinase | 0.531 | 0.692 | 2.7E-11 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DEAF1 transcription factor | 0.575 | 0.615 | 3.4E-04 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
pre-mRNA processing factor 8 | 0.631 | 0.615 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
patatin like phospholipase domain containing 6 | 0.533 | 0.769 | 1.9E-13 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 27 | 0.670 | 0.462 | 5.9E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
midline 2 | 0.695 | 0.500 | 0.18 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
interleukin 1 receptor accessory protein like 1 | 0.617 | 0.692 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
polynucleotide kinase 3'-phosphatase | 0.553 | 0.692 | 3.7E-14 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAB39B, member RAS oncogene family | 0.619 | 0.615 | 0.83 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
chloride voltage-gated channel 4 | 0.587 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
tetratricopeptide repeat domain 8 | 0.631 | 0.500 | 1.2E-06 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
calcium activated nucleotidase 1 | 0.619 | 0.731 | 2.5E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclic nucleotide gated channel subunit beta 1 | 0.628 | 0.538 | 1.8E-37 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclic nucleotide gated channel subunit alpha 1 | 0.695 | 0.269 | 2.8E-11 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
prokineticin receptor 2 | 0.538 | 0.731 | 2.4E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 5 | 0.659 | 0.577 | 4.8E-06 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
zinc finger protein 513 | 0.691 | 0.346 | 0.82 |
|
disease | 0.100 | None | 0 | 0 |